Hyperuricemia and prognosis in chronic kidney disease

Hyperuricemia and prognosis in chronic kidney disease

The ratio of uricemia, magnesia, quality of life and functional reserve of the kidneys in CKD has not been completely determined yet. These rates were analysed in 145 patients, depending on the CKD 1–5 stages. The dynamics in hyperuricemia, magnesia, uricemia and BP was established to have an invers...

Full description

Bibliographic Details
Main Authors:	D.D. Ivanov, L.M. Savitska, Z.V. Babaenko
Format:	Article
Language:	English
Published:	Zaslavsky O.Yu. 2017-08-01
Series:	Počki
Subjects:	hyperuricemia and chronic kidney disease gout and chronic kidney disease quality of life in patients with chronic kidney disease Magnerot magnesemia in chronic kidney disease
Online Access:	http://kidneys.zaslavsky.com.ua/article/view/109031

Similar Items

Hyperuricemia — an independent factor for the progression of chronic kidney disease
by: M.D. Tronko, et al.
Published: (2017-04-01)

Association between hyperuricemia and hypertension in chronic kidney disease
by: QIAN Ying, MA Xiaobo, GAO Chenni, ZHANG Chunli, MA Jun, ZHANG Wen, CHEN Xiaonong
Published: (2023-04-01)

Association of hyperuricemia and serum uric acid lowering therapy with mortality in hemodialysis patients
by: Benjamin Rohn, et al.
Published: (2020-01-01)

Hyperuricemia and the problem of chronic kidney disease
by: A V Shcherbak, et al.
Published: (2013-06-01)

A Chronic Untreated Tophaceous Gout with Dilated Cardiomyopathy and Chronic Kidney Disease: A Rare Case Report
by: Soma Srinivas Vejendla, et al.
Published: (2023-07-01)

Ultrasonographic findings in patients with chronic kidney disease with asymptomatic hyperuricemia
by: Nashwa Ismail Hashaad, et al.
Published: (2022-10-01)

Hyperuricemia in predialysis chronic kidney disease patients in Southern Nigeria
by: Oluseyi A Adejumo, et al.
Published: (2016-01-01)

EFFECTIVENESS OF CANEPHRON® N IN THE COMPLEX MANAGEMENT OF SUBCLINICAL GOUTY NEPHROPATHY
by: S. I. Smiyan, et al.
Published: (2016-05-01)

Renoprotective effects of febuxostat compared with allopurinol in patients with hyperuricemia: A systematic review and meta-analysis
by: Sollip Kim, et al.
Published: (2017-09-01)

Hyperuricemia and Progression of Chronic Kidney Disease: A Review from Physiology and Pathogenesis to the Role of Urate-Lowering Therapy
by: Tao Han Lee, et al.
Published: (2021-09-01)

Physicians' perceptions of asymptomatic hyperuricemia in patients with chronic kidney disease: A questionnaire survey
by: Ran-hui Cha, et al.
Published: (2019-09-01)

Asymptomatic hyperuricemia: secret relationships, invisible effects and potential complications
by: I. Yu. Golovach, et al.
Published: (2021-01-01)

Hyperuricemia and its related histopathological features on renal biopsy
by: Shulei Fan, et al.
Published: (2019-03-01)

Role of asymptomatic hyperuricemia in the progression of chronic kidney disease and cardiovascular disease
by: Yousuf Waheed, et al.
Published: (2021-11-01)

Hyperuricemia and Hypertension: Links and Risks
by: Stewart DJ, et al.
Published: (2019-12-01)

The effect of antioxidant therapy on the course of predialysis chronic kidney disease in a patient with comorbidity
by: L.D. Denova
Published: (2023-09-01)

The Pattern of Allopurinol Prescription Among Chronic Kidney Disease Patients in a Tertiary Care Centre: A Single-Centre Experience
by: Alobaidi S, et al.
Published: (2021-03-01)

Hyperuricemia and Associated Factors in Children with Chronic Kidney Disease: A Cross-Sectional Study
by: Jie Xu, et al.
Published: (2021-12-01)

Effectiveness of Drug Treatments for Lowering Uric Acid on Renal Function in Patients With Chronic Kidney Disease and Hyperuricemia: A Network Meta-Analysis of Randomized Controlled Trials
by: Xiang Liu, et al.
Published: (2021-08-01)

Assessment of the efficacy of hemodialysis on uric acid clearance in a sub-Saharan African population at the end stage kidney disease
by: Marie Doualla, et al.
Published: (2020-08-01)

Association between hyperuricemia and chronic kidney disease: a cross-sectional study in Bangladeshi adults
by: Zitu Barman, et al.
Published: (2023-02-01)

Hyperuricemia—a serious complication among patients with chronic kidney disease: a systematic review and meta-analysis
by: Ishfaq Rashid, et al.
Published: (2022-06-01)

Molecular Biological and Clinical Understanding of the Pathophysiology and Treatments of Hyperuricemia and Its Association with Metabolic Syndrome, Cardiovascular Diseases and Chronic Kidney Disease
by: Hidekatsu Yanai, et al.
Published: (2021-08-01)

Dotinurad restores exacerbated kidney dysfunction in hyperuricemic patients with chronic kidney disease
by: Hoichi Amano, et al.
Published: (2024-03-01)

Uric Acid and its Role in the Progression of Chronic Kidney Disease: Do We Know Enough?
by: L.M. Savytska
Published: (2016-02-01)

Treating Hyperuricemia: The Last Word Hasn’t Been Said Yet
by: Elisa Russo, et al.
Published: (2021-02-01)

Postpartum progression of chronic kidney disease in patients with chronic glomerulonephritis
by: Darya V. Gubina, et al.
Published: (2023-10-01)

Gender-specific association between uric acid level and chronic kidney disease in the elderly health checkup population in China
by: Yanlang Yang, et al.
Published: (2019-01-01)

Effect of chronic kidney disease on the association between hyperuricemia and new‐onset hypertension in the general Japanese population: ISSA‐CKD study
by: Miki Kawazoe, et al.
Published: (2021-12-01)

Asymptomatic hyperuricemia and chronic kidney disease: Narrative review of a treatment controversial
by: Theodoros Eleftheriadis, et al.
Published: (2017-09-01)

The Impact of Infections on the Progression of Chronic Kidney Disease
by: Ioana Dicu-Andreescu, et al.
Published: (2023-10-01)

A crosssectional observational research on assessment of patterns of discharge medications in patients with chronic kidney disease associated with diabetes mellitus and hypertension
by: Cyril Sajan, et al.
Published: (2024-01-01)

Alterations of gut microbiota and metabolome in early chronic kidney disease patients complicated with hyperuricemia
by: Ping Liu, et al.
Published: (2023-09-01)

Interaction between anemia and hyperuricemia in the risk of all-cause mortality in patients with chronic kidney disease
by: Zhaoxuan Lu, et al.
Published: (2024-03-01)

Chronic kidney disease in the Swiss population
by: Bruno Vogt
Published: (2016-04-01)

A review on the classification and current treatment of Chronic Kidney Disease
by: Michał Żuberek, et al.
Published: (2023-12-01)

Simple Renal Ectopia with Chronic Kidney Disease
by: Sudhanshu Ku Das, et al.
Published: (2013-01-01)

Hyperuricemia and diabetes mellitus when occurred together have higher risks than alone on all-cause mortality and end-stage renal disease in patients with chronic kidney disease
by: Cheng-Hung Li, et al.
Published: (2022-04-01)

Analysis of the course and outcomes of pregnancy in patients with advanced stages chronic kidney disease
by: Kseniia A. Demyanova, et al.
Published: (2021-06-01)

Chronic kidney disease: The emerging challenge and the way forward
by: Geetha Mani, et al.
Published: (2015-07-01)